Wellington Management Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-150,873
| Closed | -$2.37M | – | 1995 |
|
|
2024
Q1 | $2.37M | Buy |
150,873
+102,327
| +211% | +$1.57M | ﹤0.01% | 1486 |
|
|
2023
Q4 | $783K | Buy |
+48,546
| New | +$619K | ﹤0.01% | 1659 |
|
|
2023
Q2 | – | Sell |
-79,289
| Closed | -$1.23M | – | 2056 |
|
|
2023
Q1 | $1.23M | Sell |
79,289
-34,838
| -31% | -$582K | ﹤0.01% | 1601 |
|
|
2022
Q4 | $1.87M | Sell |
114,127
-5,189
| -4% | -$84.4K | ﹤0.01% | 1525 |
|
|
2022
Q3 | $2.21M | Buy |
119,316
+54,024
| +83% | +$848K | ﹤0.01% | 1505 |
|
|
2022
Q2 | $859K | Sell |
65,292
-369
| -0.6% | -$4.07K | ﹤0.01% | 1704 |
|
|
2022
Q1 | $608K | Sell |
65,661
-159,940
| -71% | -$1.36M | ﹤0.01% | 1858 |
|
|
2021
Q4 | $2.2M | Buy |
225,601
+24,715
| +12% | +$465K | ﹤0.01% | 1639 |
|
|
2021
Q3 | $6.83M | Sell |
200,886
-477
| -0.2% | -$15.2K | ﹤0.01% | 1405 |
|
|
2021
Q2 | $7.37M | Sell |
201,363
-1,115
| -0.6% | -$43.2K | ﹤0.01% | 1379 |
|
|
2021
Q1 | $9.08M | Sell |
202,478
-5,146
| -2% | -$240K | ﹤0.01% | 1264 |
|
|
2020
Q4 | $11.8M | Buy |
207,624
+98,054
| +89% | +$5.81M | ﹤0.01% | 1147 |
|
|
2020
Q3 | $5.62M | Buy |
+109,570
| New | +$5.37M | ﹤0.01% | 1242 |
|
|
2020
Q1 | – | Sell |
-5,800
| Closed | -$361K | – | 2079 |
|
|
2019
Q4 | $361K | Sell |
5,800
-3,631
| -39% | -$173K | ﹤0.01% | 1913 |
|
|
2019
Q3 | $320K | Buy |
+9,431
| New | +$279K | ﹤0.01% | 1942 |
|
|
2017
Q4 | – | Sell |
-14,044
| Closed | -$267K | – | 2322 |
|
|
2017
Q3 | $267K | Buy |
+14,044
| New | +$257K | ﹤0.01% | 2142 |
|
Other funds holding DCPH
Wellington Management Group's DCPH Position: Q2 2024 in Review
Wellington Management Group sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 150,873 shares — an estimated $2.37M sold.
Wellington Management Group first reported a position in DCPH in Q3 2017 and held it in 16 quarters. The position peaked at $11.8M in Q4 2020. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Wellington Management Group reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Wellington Management Group sold 150,873 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $2.37M.
- Wellington Management Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 16 quarters.
- Wellington Management Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $11.8M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Wellington Management Group's 13F filing for Q2 2024, filed 14 Aug 2024.